Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Long Term Outcome After Low Dose TBI Based Conditioning Hematopoietic Stem Cell Transplantation (HSCT) From Related and Unrelated Donors for Older Patients with AML

Dietger Niederwieser, MD, Leo F Verdonck, Jan J Cornelissen, MD PhD, Michael Cross, PhD, Rainer Krahl, MD, Thoralf Lange, Vladan Vucinic, Georg Franke, MD, Haifa K. Al-Ali, MD, Gert Ossenkoppele, MD, PhD, Georg Maschmeyer, MD, Gottfried Doelken, MD, Mathias Freund, MD, Norma Peter, Marc Boogaerts, MD, PhD, Alois Gratwohl, MD, Harry C. Schouten, MD, PhD, Bob Lowenberg, MD, PhD

Blood (2011) 118 (21): 2030.

https://doi.org/10.1182/blood.V118.21.2030.2030

Published: 2011

Journal Articles

High Impact of Human Leukocyte Antigen Matching On Overall Survival and Transplant Related Mortality in Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Long-Term Study From the EBMT Registry.

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M, Stéphane Morisset, MSc, Dietger Niederwieser, MD, Vladimir Koza, MD, Tapani Ruutu, MD, Nigel H. Russell, MD, Leo Verdonck, MD, Donald Milligan, MD, Nathalie Dhedin, MD, Tomas Kozak, Marc Boogaerts, MD, PhD, Juergen Finke, MD, Valérie Dubois, MD, Anja van Biezen, Ronald Brand, Theo de Witte, MD, Peter Dreger, MD

Blood (2009) 114 (22): 2286.

https://doi.org/10.1182/blood.V114.22.2286.2286

Published: 2009

Journal Articles

Early Consolidation with Myeloablative Radiochemotherapy Followed by Autologous Stem Cell Transplantation in First Remission in Mantle Cell Lymphoma: Long Term Follow up of a Randomized Trial of the

Martin H. Dreyling, MD, Eva Hoster, PhD, Achiel Van Hoof, Bernd Metzner, Christian Gisselbrecht, Michael Pfreundschuh, MD, PhD, Marcel Reiser, Lorenz H. Truemper, MD, PhD, Hjalmar Steinhauer, Jean-Michel Boiron, MD, PhD, Marc Boogaerts, MD, PhD, Vittorio Silingardi, J.C. Kluin- Nelemans, MD, PhD, Michael Unterhalt, Wolfgang Hiddemann

Blood (2008) 112 (11): 769.

https://doi.org/10.1182/blood.V112.11.769.769

Published: 2008

Journal Articles

Standard and Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantations (HSCT) from Related and Unrelated Donors for Chronic Lymphocytic Leukemia (CLL). a Long-Term Follow-up (10 years) Study from the EBMT Registry. (CLL Sub-Committee on Behalf of EBMT CLWP)

Mauricette Michallet, MD, PhD, Quoc Hung Le, MD, Peter Dreger, Mohamad Sobh, PhD, Dietger Niederwieser, MD, Vladimir Koza, MD, Tapani Ruutu, Nigel H. Russell, MD, Leo Verdonck, Donald Milligan, MD, MBChB, Nathalie Dhedin, Tomas Kozak, MD, PhD, Marc Boogaerts, MD, PhD, Juergen Finke, Nathalie Tedone, Anja Van Biezen, Ronald Brand, Theo de Witte on behalfhe European Group for Blood Marrow Transplantation

Blood (2008) 112 (11): 566.

https://doi.org/10.1182/blood.V112.11.566.566

Published: 2008

Journal Articles

The Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents with Recurring Hodgkin’s Lymphoma: An EBMT Study on 151 Patients.

Alexander Claviez, MD, Carmen Canals, Marc Boogaerts, MD, Jerry Stein, MD, Stephen Mackinnon, MD, Rodrigo Martino, MD, Andrea Pession, MD, Shimon Slavin, MD, Charles Craddock, MD, Ioanna Sakellari, MD, Paolo Corradini, MD, Alessandro Rambaldi, MD, Meinolf Suttorp, MD, Giorgio Dini, MD, Anna Sureda, MD, Norbert Schmitz, MD

Blood (2007) 110 (11): 3061.

https://doi.org/10.1182/blood.V110.11.3061.3061

Published: 2007

Journal Articles

Matched Unrelated Donor Stem Cell Transplantation for Relapsed or Refractory Mantle Cell Lymphoma. A Retrospective Analysis from the EBMT Lymphoma Working Party.

Irit Avivi, MD, PhD, Carme Canals, MD, Goli Taghipour, Jurgen Finke, MD, PhD, Liisa Volin, MD, PhD, Yves Beguin, MD, PhD, Marc Boogaerts, MD, PhD, Charles Crawley, MD, PhD, Michael Rieger, MD, Norbert Schmitz, MD, PhD, Guido Kobbe, MD, PhD, Donald Milligan, MD, PhD, Dietger W. Niederwieser, MD, PhD, Nigel H. Russell, MD, PhD, Rainer Schwerdtfeger, MD, PhD, Anna Sureda, MD

Blood (2006) 108 (11): 3123.

https://doi.org/10.1182/blood.V108.11.3123.3123

Published: 2006

Journal Articles

Natural History of Post-Allogeneic HSCT EBV-Reactivation: A Single Center Retrospective Survey.

Helene M. Schoemans, MD, Koen Theunissen, MD, Marc Boogaerts, MD, PhD, Johan Maertens, MD

Blood (2005) 106 (11): 3232.

https://doi.org/10.1182/blood.V106.11.3232.3232

Published: 2005

Journal Articles

Treatment-Related MDS/AML after Autologous Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL): An EBMT Survey.

Peter Dreger, MD, Anja van Biezen, Kees Brukx, Marc Boogaerts, MD, Mauricette Michallet, MD, Donald Milligan, MD, Dietger W. Niederwieser, MD

Blood (2005) 106 (11): 1122.

https://doi.org/10.1182/blood.V106.11.1122.1122

Published: 2005

Journal Articles

Chromosomal Rearrangements Affecting ABL1 in T-Cell Acute Lymphoblastic Leukemia.

Jan Cools, PhD, Carlos Graux, MD, Marc Boogaerts, MD, PhD, Peter Vandenberghe, MD, PhD, Iwona Wlodarska, PhD, Peter Marynen, PhD, Anne Hagemeijer, MD, PhD

Blood (2004) 104 (11): 2894.

https://doi.org/10.1182/blood.V104.11.2894.2894

Published: 2004

Journal Articles

Fludarabine Phosphate-Based Nonmyeloablative Stem Cell Transplantation in the Elderly Patients: A BHS Study.

Dominique Bron, MD, PhD, Pierre Zachée, MD, Johan Maertens, MD, Koen Theunissen, MD, Augustin Ferrant, MD, PhD, Philippe Martiat, MD, PhD, Chantal Doyen, MD, Luc Noens, MD, Wilfried Schroyens, MD, Dominique Sellesslag, MD, Hilde Demuynck, MD, Rick Schots, MD, PhD, Anne De Meuter, Marc Boogaerts, MD, PhD

Blood (2004) 104 (11): 5046.

https://doi.org/10.1182/blood.V104.11.5046.5046

Published: 2004

Journal Articles

Targeted Pre-Emptive Anti- Aspergillus Therapy in Neutropenic Patients Not Receiving Empirical Antifungal Therapy.

Johan A. Maertens, MD, Koen Theunissen, MD, Gregor Verhoef, MD, Johnny Verschaekelen, MD, PhD, Katrien Lagrou, MD, PhD, Eric Verbeken, MD, PhD, Jan Verhaegen, MD, PhD, Wouter Meersseman, MD, Alexander Wilmer, MD, PhD, Marc Boogaerts, MD, PhD, Johan Van Eldere, MD, PhD

Blood (2004) 104 (11): 2231.

https://doi.org/10.1182/blood.V104.11.2231.2231

Published: 2004

NARROW

Long Term Outcome After Low Dose TBI Based Conditioning Hematopoietic Stem Cell Transplantation (HSCT) From Related and Unrelated Donors for Older Patients with AML

High Impact of Human Leukocyte Antigen Matching On Overall Survival and Transplant Related Mortality in Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Long-Term Study From the EBMT Registry.

Early Consolidation with Myeloablative Radiochemotherapy Followed by Autologous Stem Cell Transplantation in First Remission in Mantle Cell Lymphoma: Long Term Follow up of a Randomized Trial of the

Standard and Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantations (HSCT) from Related and Unrelated Donors for Chronic Lymphocytic Leukemia (CLL). a Long-Term Follow-up (10 years) Study from the EBMT Registry. (CLL Sub-Committee on Behalf of EBMT CLWP)

The Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents with Recurring Hodgkin’s Lymphoma: An EBMT Study on 151 Patients.

Matched Unrelated Donor Stem Cell Transplantation for Relapsed or Refractory Mantle Cell Lymphoma. A Retrospective Analysis from the EBMT Lymphoma Working Party.

Natural History of Post-Allogeneic HSCT EBV-Reactivation: A Single Center Retrospective Survey.

Treatment-Related MDS/AML after Autologous Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL): An EBMT Survey.

Chromosomal Rearrangements Affecting ABL1 in T-Cell Acute Lymphoblastic Leukemia.

Fludarabine Phosphate-Based Nonmyeloablative Stem Cell Transplantation in the Elderly Patients: A BHS Study.

Targeted Pre-Emptive Anti- Aspergillus Therapy in Neutropenic Patients Not Receiving Empirical Antifungal Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only